Advertisement

Pediatrics Type 2 Diabetes Guidelines Published — Physician’s First Watch

Medical News |
January 29, 2013

Pediatrics Type 2 Diabetes Guidelines Published

By Cara Adler

The American Academy of Pediatrics has issued a clinical practice guideline for the management of newly diagnosed type 2 diabetes in those aged 10 to 18 years. Published in Pediatrics, the guideline recommends that clinicians:

  • start insulin therapy for patients with ketosis or ketoacidosis, patients in whom type 1 and type 2 disease can't be distinguished, and patients with blood glucose at or above 250 mg/dL or HbA1c >9%;

  • initiate a lifestyle modification program and metformin therapy for other patients;

  • monitor HbA1c concentrations every 3 months and intensify treatment if HbA1c and blood glucose goals are not met;

  • advise finger-stick blood glucose monitoring for patients who are on medications that can cause hypoglycemia, are starting or changing diabetes treatment, have not met treatment goals, or have other illnesses;

  • counsel patients about diet and nutrition;

  • encourage patients to exercise for at least 1 hour a day.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement